Videos

Mary Pilarz, MD, highlights how allowing families to initiate interpreter use in the PICU boosts utilization and may improve communication equity.

Findings by Conall Watson, PhD, MSc, highlight that maternal RSV vaccination significantly reduces infant hospitalizations—even when given late in pregnancy.

A nationwide analysis of nearly 300,000 infants found that maternal RSV vaccination reduced severe infant hospitalizations by over 80%.

Jennifer Dantzer, MD, discusses how environmental and genetic factors and clinical features shape the diagnosis and management of seasonal allergies in children.

New evidence using sibling-matched analyses suggests no meaningful association between prenatal acetaminophen use and autism.

Henry Xiang, MD, PhD, highlights the importance of thorough follow-up and family resilience in managing mental health outcomes after traumatic brain injury.

Mary Beth Howard, MD, MSc, says rising injury rates among young adolescents reflect a mismatch among rider maturity, high-speed devices, and unsafe riding environments.

Experts say social media–fueled misinformation and evolving policy landscapes are increasing vaccine hesitancy.

Katharine P. Callahan, MD, MSME, highlights how rapid genomic testing in neonatal intensive care offers critical diagnostic and prognostic insight.

Tami Katzir, PhD, and Rotem Yinon, PhD, discuss emerging evidence that brief kindergarten screening tools can identify dyslexia risk across development.

Trofinetide offers the first targeted treatment for Rett syndrome, with a new, convenient powdered formulation aimed at significantly reducing adverse effects.

Lara McKenzie, PhD, emphasizes the urgent need for strong child-resistant packaging to prevent accidental exposures.

Data found that mavacamten significantly reduces cardiac obstruction and improves clinical markers in adolescents with symptomatic obstructive hypertrophic cardiomyopathy.

The FDA has updated its approval for 1-mg epinephrine nasal spray, removing the age limit to allow all patients weighing at least 33 lb to access the treatment.

Rachel Rosales, MPH, explores how mandatory reporting and integrated care models can address the structural barriers preventing consistent behavioral health screenings.

As we step into Q2 2026, take a look back at our top video interviews and packages of Q1.

Perry Rosen, MD, offers essential guidance for clinicians on prevention and emergency management of pediatric nicotine poisoning.

A 7460% increase in pediatric inhalation exposures since 2016 highlights the need for child-resistant designs and updated parental guidance.

Linda Stein Gold, MD, discusses the promising safety and efficacy of tapinarof cream, 1%, as a nonsteroidal treatment for pediatric patients with atopic dermatitis.

Jennifer Hoffmann, MD, MS, discusses the high rates of overtriage in children with behavioral health symptoms and the need for more objective triage tools.

Margeaux Naughton, MD, discusses the Pediatric Psychiatry Colocalized Consult Clinic model, a strategic approach to improve mental health access and provider training.

Ashley Shoemaker, MD, MSci, discusses the evolving clinical pathways for managing rare genetic and acquired hypothalamic obesity in pediatric patients.

The FDA approval of setmelanotide for patients 4 years and older offers a targeted therapy to address the underlying biology of acquired hypothalamic obesity.

Clinical and family goals should guide the selection between high-dose CIMT and bimanual therapy.

Shara Bialo, MD, explains why immunologic screening for islet autoantibodies is essential to identifying type 1 diabetes in its presymptomatic stages.

Palynziq provides a significant new genotype-independent therapy for patients 12 years and older to help manage and reduce blood phenylalanine levels.

Chad Wells, PhD, shares evidence-based strategies to improve MenACWY 2-dose series completion and address racial and socioeconomic disparities in vaccination.

Kathleen Adelgais, MD, MPH, highlights the critical role of family-centered protocols in overcoming readiness barriers and improving emergency outcomes for children.

A first-of-its-kind approval for hypothalamic obesity offers earlier, targeted treatment in children.

Kathleen Adelgais, MD, MPH, discusses how pediatric emergency care coordinators and family-centered protocols improve emergency outcomes for children.